{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:29:59Z","timestamp":1789039799231,"version":"build-2803163510"},"reference-count":144,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jaci.2020.10.043","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:42:50Z","timestamp":1607474570000},"page":"827-844","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":114,"title":["The role of aspirin desensitization followed by oral aspirin therapy in managing patients with aspirin-exacerbated respiratory disease: A\u00a0Work Group Report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of Allergy, Asthma & Immunology"],"prefix":"10.1016","volume":"147","author":[{"given":"Whitney W.","family":"Stevens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elina","family":"Jerschow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan P.","family":"Baptist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Borish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John V.","family":"Bosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Buchheit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine N.","family":"Cahill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong H.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjeni","family":"Keswani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua M.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Nanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya M.","family":"Laidlaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2020.10.043_bib1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaci.2011.01.065","article-title":"Reduced expression of COXs and production of prostaglandin E(2) in patients with nasal polyps with or without aspirin-intolerant asthma","volume":"128","author":"Roca-Ferrer","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib2","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1164\/ajrccm\/143.5_Pt_1.1025","article-title":"Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects","volume":"143","author":"Christie","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2020.10.043_bib3","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jaci.2005.02.029","article-title":"Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis","volume":"115","author":"Perez-Novo","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaci.2014.07.031","article-title":"Prostaglandin D(2): a dominant mediator of aspirin-exacerbated respiratory disease","volume":"135","author":"Cahill","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib5","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2014.08.020","article-title":"Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature","volume":"135","author":"Rajan","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib6","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jaip.2016.12.027","article-title":"Clinical characteristics of patients with chronic rhinosinusitis with nasal polyps, asthma, and aspirin-exacerbated respiratory disease","volume":"5","author":"Stevens","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.10.043_bib7","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jaci.2016.05.048","article-title":"Automated identification of an aspirin-exacerbated respiratory disease cohort","volume":"139","author":"Cahill","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.anai.2014.07.025","article-title":"Diagnosis and management of rhinosinusitis: a practice parameter update","volume":"113","author":"Peters","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib9","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1016\/j.jaip.2019.03.023","article-title":"Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma","volume":"7","author":"Bachert","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.10.043_bib10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/000348941112000304","article-title":"Revision rates after endoscopic sinus surgery: a recurrence analysis","volume":"120","author":"Mendelsohn","year":"2011","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jaci.2020.10.043_bib11","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2500\/ajr.2007.21.3108","article-title":"Long-term outcome analysis of endoscopic sinus surgery for chronic sinusitis","volume":"21","author":"Young","year":"2007","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.jaci.2020.10.043_bib12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1067\/mai.2003.7","article-title":"Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease","volume":"111","author":"Berges-Gimeno","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib13","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00405-012-2048-x","article-title":"Sinonasal outcome under aspirin desensitization following functional endoscopic sinus surgery in patients with aspirin triad","volume":"270","author":"Havel","year":"2013","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jaci.2020.10.043_bib14","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/1945892418770260","article-title":"Long-term clinical outcomes of aspirin desensitization with continuous daily aspirin therapy in aspirin-exacerbated respiratory disease","volume":"32","author":"Walters","year":"2018","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaci.2020.10.043_bib15","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1056\/NEJMra1712125","article-title":"Aspirin-exacerbated respiratory disease","volume":"379","author":"White","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2020.10.043_bib16","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0002-8703(98)70036-5","article-title":"Early assessment and in-hospital management of patients with acute myocardial infarction at increased risk for adverse outcomes: a nationwide perspective of current clinical practice. The National Registry of Myocardial Infarction (NRMI-2) Participants","volume":"135","author":"Becker","year":"1998","journal-title":"Am Heart J"},{"key":"10.1016\/j.jaci.2020.10.043_bib17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/all.13599","article-title":"Diagnosis and management of NSAID-exacerbated respiratory disease (N-ERD)\u2014a EAACI position paper","volume":"74","author":"Kowalski","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.10.043_bib18","first-page":"189","article-title":"Anaphylaxie et idiosyncrasie","volume":"30","author":"Widal","year":"1922","journal-title":"Presse Med"},{"key":"10.1016\/j.jaci.2020.10.043_bib19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2500\/108854193778773985","article-title":"Widal on the aspirin triad and induction of tolerance","volume":"14","author":"Klion","year":"1993","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2020.10.043_bib20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/02770908709070955","article-title":"Treasure hunt: pertinent excerpts from past literature","volume":"24","year":"1987","journal-title":"J Asthma"},{"key":"10.1016\/j.jaci.2020.10.043_bib21","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/0091-6749(76)90059-2","article-title":"Refractory period to aspirin in a patient with aspirin-induced asthma","volume":"57","author":"Zeiss","year":"1976","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0091-6749(80)90143-8","article-title":"Aspirin-sensitive asthma: tolerance to aspirin after positive oral aspirin challenges","volume":"66","author":"Stevenson","year":"1980","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib23","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/0091-6749(83)90440-2","article-title":"Aspirin-sensitive rhinosinusitis: the clinical syndrome and effects of aspirin administration","volume":"71","author":"Lumry","year":"1983","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib24","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0091-6749(96)70123-9","article-title":"Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes","volume":"98","author":"Stevenson","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib25","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1081-1206(10)61803-0","article-title":"Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease","volume":"90","author":"Berges-Gimeno","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jaci.2006.09.011","article-title":"Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease","volume":"119","author":"Lee","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib27","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/0194599814545750","article-title":"Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease","volume":"151","author":"Cho","year":"2014","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaci.2020.10.043_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/alr.22036","article-title":"Outcomes after complete endoscopic sinus surgery and aspirin desensitization in aspirin-exacerbated respiratory disease","volume":"8","author":"Adappa","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaci.2020.10.043_bib29","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/alr.22418","article-title":"Endoscopic sinus surgery improves aspirin treatment response in AERD patients","volume":"9","author":"Shah","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaci.2020.10.043_bib30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0091-6749(90)90222-P","article-title":"Long-term effects of aspirin desensitization--treatment for aspirin-sensitive rhinosinusitis-asthma","volume":"85","author":"Sweet","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib31","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1398-9995.2008.01658.x","article-title":"Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin daily","volume":"63","author":"Rozsasi","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.10.043_bib32","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/all.12269","article-title":"Aspirin 300 mg\/day is effective for treating aspirin-exacerbated respiratory disease","volume":"68","author":"Comert","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.10.043_bib33","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jaip.2016.11.021","article-title":"Plasma 15-hydroxyeicosatetraenoic acid predicts treatment outcomes in aspirin-exacerbated respiratory disease","volume":"5","author":"Jerschow","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.10.043_bib34","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2500\/ajr.2006.20.2913","article-title":"Medical and surgical considerations in patients with Samter\u2019s triad","volume":"20","author":"McMains","year":"2006","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.jaci.2020.10.043_bib35","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/alr.21826","article-title":"Contemporary management of chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease: an evidence-based review with recommendations","volume":"6","author":"Levy","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaci.2020.10.043_bib36","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/0091-6749(84)90361-0","article-title":"Aspirin-sensitive rhinosinusitis asthma: a double-blind crossover study of treatment with aspirin","volume":"73","author":"Stevenson","year":"1984","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib37","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaci.2014.02.041","article-title":"Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study","volume":"134","author":"Swierczynska-Krepa","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib38","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.clim.2015.05.012","article-title":"Aspirin desensitization for patients with aspirin-exacerbated respiratory disease: a randomized double-blind placebo-controlled trial","volume":"160","author":"Esmaeilzadeh","year":"2015","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib39","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/all.12131","article-title":"Low-dose aspirin desensitization in individuals with aspirin-exacerbated respiratory disease","volume":"68","author":"Fruth","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.10.043_bib40","first-page":"1639","article-title":"Clinical and immunological efficacy of aspirin desensitization in nasal polyp patients with aspirin-exacerbated respiratory disease","volume":"16","author":"Mortazavi","year":"2017","journal-title":"Iran J Pharm Res"},{"key":"10.1016\/j.jaci.2020.10.043_bib41","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/alr.22428","article-title":"Benefits and harms of aspirin desensitization for aspirin-exacerbated respiratory disease: a systematic review and meta-analysis","volume":"9","author":"Chu","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaci.2020.10.043_bib42","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1164\/ajrccm.151.5.7735581","article-title":"The effect of aspirin desensitization on urinary leukotriene E4 concentrations in aspirin-sensitive asthma","volume":"151","author":"Nasser","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2020.10.043_bib43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.rmed.2018.08.009","article-title":"Aspirin desensitization in aspirin-exacerbated respiratory disease: new insights into the molecular mechanisms","volume":"143","author":"Bobolea","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.jaci.2020.10.043_bib44","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1164\/rccm.201809-1755OC","article-title":"Unique effect of aspirin therapy on biomarkers in aspirin-exacerbated respiratory disease: a prospective trial","volume":"200","author":"Cahill","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2020.10.043_bib45","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJMoa013508","article-title":"Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis","volume":"347","author":"Sousa","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2020.10.043_bib46","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1164\/ajrccm\/140.1.148","article-title":"Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma","volume":"140","author":"Arm","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2020.10.043_bib47","doi-asserted-by":"crossref","first-page":"10967","DOI":"10.1074\/jbc.C113.453704","article-title":"Identification of GPR99 protein as a potential third cysteinyl leukotriene receptor with a preference for leukotriene E4 ligand","volume":"288","author":"Kanaoka","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2020.10.043_bib48","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1183\/09031936.93.06101468","article-title":"Airway responsiveness to leukotriene C4 (LTC4), leukotriene E4 (LTE4) and histamine in aspirin-sensitive asthmatic subjects","volume":"6","author":"Christie","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2020.10.043_bib49","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0091-6749(99)70324-6","article-title":"Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses","volume":"104","author":"Daffern","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib50","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1182\/blood.V97.6.1742","article-title":"Selective inhibition of interleukin-4 gene expression in human T cells by aspirin","volume":"97","author":"Cianferoni","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.10.043_bib51","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jaci.2009.07.031","article-title":"Modulation by aspirin of nuclear phospho-signal transducer and activator of transcription 6 expression: possible role in therapeutic benefit associated with aspirin desensitization","volume":"124","author":"Steinke","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib52","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jaci.2010.06.036","article-title":"The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases","volume":"126","author":"Katial","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib53","article-title":"Interleukin-4 in the generation of the AERD phenotype: implications for molecular mechanisms driving therapeutic benefit of aspirin desensitization","volume":"2012","author":"Steinke","year":"2012","journal-title":"J Allergy (Cairo)"},{"key":"10.1016\/j.jaci.2020.10.043_bib54","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1084\/jem.193.1.123","article-title":"T helper cell type 2 cytokines coordinately regulate immunoglobulin E-dependent cysteinyl leukotriene production by human cord blood-derived mast cells: profound induction of leukotriene C(4) synthase expression by interleukin 4","volume":"193","author":"Hsieh","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2020.10.043_bib55","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jaci.2018.10.007","article-title":"Plasma tryptase elevation during aspirin-induced reactions in aspirin-exacerbated respiratory disease","volume":"143","author":"Cahill","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib56","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jaci.2016.04.042","article-title":"Eosinophil production of prostaglandin D2 in patients with aspirin-exacerbated respiratory disease","volume":"138","author":"Feng","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib57","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000155743","article-title":"Expression and characterization of PGD2 receptors in chronic rhinosinusitis: modulation of DP and CRTH2 by PGD2","volume":"148","author":"Yamamoto","year":"2009","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib58","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1056\/NEJMcibr1514013","article-title":"Aspirin-exacerbated respiratory disease--new prime suspects","volume":"374","author":"Laidlaw","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2020.10.043_bib59","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1067\/mai.2003.1387","article-title":"A controlled study of 9alpha,11beta-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge","volume":"111","author":"Bochenek","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib60","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.jaci.2013.12.1034","article-title":"Prostaglandin E2 resistance in granulocytes from patients with aspirin-exacerbated respiratory disease","volume":"133","author":"Laidlaw","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib61","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaci.2015.09.028","article-title":"Low E-prostanoid 2 receptor levels and deficient induction of the IL-1beta\/IL-1 type I receptor\/COX-2 pathway: vicious circle in patients with aspirin-exacerbated respiratory disease","volume":"137","author":"Machado-Carvalho","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib62","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4193\/Rhino15.207","article-title":"Altered expression and signalling of EP2 receptor in nasal polyps of AERD\u00a0patients: role in inflammation and remodelling","volume":"54","author":"Machado-Carvalho","year":"2016","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2020.10.043_bib63","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1182\/blood-2011-10-384826","article-title":"Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes","volume":"119","author":"Laidlaw","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.10.043_bib64","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1034\/j.1399-3003.2000.016003432.x","article-title":"Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma","volume":"16","author":"Szczeklik","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2020.10.043_bib65","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7326\/0003-4819-68-5-975","article-title":"Intolerance to aspirin: clinical studies and consideration of its pathogenesis","volume":"68","author":"Samter","year":"1968","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaci.2020.10.043_bib66","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1164\/ajrccm\/148.6_Pt_1.1447","article-title":"The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin","volume":"148","author":"Israel","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2020.10.043_bib67","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S1081-1206(10)62575-6","article-title":"Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics","volume":"85","author":"Stevenson","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib68","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1080\/02770903.2018.1490754","article-title":"Depression symptoms and quality of life among individuals with aspirin-exacerbated respiratory disease","volume":"56","author":"Feldman","year":"2019","journal-title":"J Asthma"},{"key":"10.1016\/j.jaci.2020.10.043_bib69","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jaip.2015.01.007","article-title":"Tolerance of daily low-dose aspirin does not preclude aspirin-exacerbated respiratory disease","volume":"3","author":"Lee-Sarwar","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.10.043_bib70","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.jaip.2018.12.014","article-title":"Sinus surgery is associated with a decrease in aspirin-induced reaction severity in patients with aspirin exacerbated respiratory disease","volume":"7","author":"Jerschow","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.10.043_bib71","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.jaip.2019.02.037","article-title":"Sinus surgery improves lower respiratory tract reactivity during aspirin desensitization for AERD","volume":"7","author":"Huang","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.10.043_bib72","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2020.10.043_bib73","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/uog.18992","article-title":"Maternal blood-pressure trends throughout pregnancy and development of pre-eclampsia in women receiving first-trimester aspirin prophylaxis","volume":"52","author":"Baschat","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jaci.2020.10.043_bib74","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/OGX.0b013e31815e8731","article-title":"Aspirin and reproductive outcomes","volume":"63","author":"James","year":"2008","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.jaci.2020.10.043_bib75","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1056\/NEJM197609022951004","article-title":"Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis","volume":"295","author":"Heymann","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2020.10.043_bib76","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ajg.2011.480","article-title":"Management of patients with ulcer bleeding","volume":"107","author":"Laine","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2020.10.043_bib77","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jaip.2018.09.012","article-title":"A retrospective analysis of esophageal eosinophilia in patients with aspirin-exacerbated respiratory disease","volume":"7","author":"Eid","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.10.043_bib78","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1056\/NEJM199905063401801","article-title":"Reye\u2019s syndrome in the United States from 1981 through 1997","volume":"340","author":"Belay","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2020.10.043_bib79","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jaip.2015.06.013","article-title":"An hourly dose-escalation desensitization protocol for aspirin-exacerbated respiratory disease","volume":"3","author":"Chen","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.10.043_bib80","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1081-1206(10)60465-6","article-title":"Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis","volume":"100","author":"Dursun","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib81","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jaci.2008.09.048","article-title":"Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease","volume":"123","author":"Hope","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib82","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/cea.12110","article-title":"Nasal lysine aspirin challenge in the diagnosis of aspirin-exacerbated respiratory disease: asthma and rhinitis","volume":"43","author":"Miller","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2020.10.043_bib83","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jaci.2017.05.006","article-title":"Safety and outcomes of aspirin desensitization for aspirin-exacerbated respiratory disease: a single-center study","volume":"141","author":"Waldram","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib84","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jaci.2007.06.047","article-title":"An economic analysis of aspirin desensitization in aspirin-exacerbated respiratory disease","volume":"121","author":"Shaker","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib85","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.anai.2019.01.018","article-title":"Cost-effectiveness and comparative effectiveness of biologic therapy for asthma: to biologic or not to biologic?","volume":"122","author":"Anderson","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib86","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1081-1206(10)61150-7","article-title":"The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease","volume":"95","author":"White","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib87","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1183\/09031936.04.00100303","article-title":"Montelukast protects against nasal lysine-aspirin challenge in patients with aspirin-induced asthma","volume":"24","author":"Lee","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2020.10.043_bib88","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1046\/j.1365-2745.2002.01501.x","article-title":"The effect of leukotriene-modifier drugs on aspirin-induced asthma and rhinitis reactions","volume":"32","author":"Berges-Gimeno","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2020.10.043_bib89","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1081-1206(10)62432-5","article-title":"Lack of effect of the 5-lipoxygenase inhibitor zileuton in blocking oral aspirin challenges in aspirin-sensitive asthmatics","volume":"85","author":"Pauls","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib90","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.iac.2016.06.006","article-title":"Performing aspirin desensitization in aspirin-exacerbated respiratory disease","volume":"36","author":"Waldram","year":"2016","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2020.10.043_bib91","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/thx.34.5.654","article-title":"Inhibition of idiosyncratic reactions to aspirin in asthmatic patients by clemastine","volume":"34","author":"Szczeklik","year":"1979","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2020.10.043_bib92","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.jaip.2018.10.032","article-title":"A 1-day, 90-minute aspirin challenge and desensitization protocol in aspirin-exacerbated respiratory disease","volume":"7","author":"DeGregorio","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.10.043_bib93","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.anai.2018.05.007","article-title":"Omalizumab can inhibit respiratory reaction during aspirin desensitization","volume":"121","author":"Lang","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib94","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.jaci.2015.09.034","article-title":"Omalizumab reduces cysteinyl leukotriene and 9alpha,11beta-prostaglandin F2 overproduction in aspirin-exacerbated respiratory disease","volume":"137","author":"Hayashi","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib95","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jaip.2016.12.013","article-title":"Aspirin tolerance in patients with nonsteroidal anti-inflammatory drug-exacerbated respiratory disease following treatment with omalizumab","volume":"5","author":"Phillips-Angles","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.10.043_bib96","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/alr.21541","article-title":"Outcomes of complete vs targeted approaches to endoscopic sinus surgery","volume":"5","author":"DeConde","year":"2015","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaci.2020.10.043_bib97","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/alr.21739","article-title":"Outcomes of modified endoscopic Lothrop in aspirin-exacerbated respiratory disease with nasal polyposis","volume":"6","author":"Morrissey","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaci.2020.10.043_bib98","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/alr.21109","article-title":"Risk factors and outcomes for primary, revision, and modified Lothrop (Draf III) frontal sinus surgery","volume":"3","author":"Naidoo","year":"2013","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaci.2020.10.043_bib99","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jaip.2018.08.004","article-title":"Comparable safety of 2 aspirin desensitization protocols for aspirin exacerbated respiratory disease","volume":"7","author":"Pelletier","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.10.043_bib100","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaci.2014.09.004","article-title":"Ramipril and metoprolol intake aggravate human and murine anaphylaxis: evidence for direct mast cell priming","volume":"135","author":"Nassiri","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib101","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.jaip.2017.12.020","article-title":"Patients taking beta-blockers do not require increased doses of epinephrine for anaphylaxis","volume":"6","author":"White","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.10.043_bib102","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1398-9995.2007.01409.x","article-title":"EAACI\/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity","volume":"62","author":"Nizankowska-Mogilnicka","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.10.043_bib103","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1081-1206(10)60692-8","article-title":"Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper","volume":"98","author":"Macy","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib104","first-page":"259","article-title":"Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma, & Immunology, American College of Allergy, Asthma, & Immunology, Joint Council of Allergy, Asthma and Immunology. Drug allergy: an updated practice parameter","volume":"105","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib105","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.anai.2010.05.020","article-title":"Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease","volume":"105","author":"Lee","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib106","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jaci.2006.06.019","article-title":"Selection of patients for aspirin desensitization treatment","volume":"118","author":"Stevenson","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib107","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1081-1206(10)60012-9","article-title":"Intranasal ketorolac challenge for the diagnosis of aspirin-exacerbated respiratory disease","volume":"97","author":"White","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib108","first-page":"588","article-title":"Intranasal treatment with lysine acetylsalicylate in patients with nasal polyposis","volume":"67","author":"Patriarca","year":"1991","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jaci.2020.10.043_bib109","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.iac.2009.07.008","article-title":"Aspirin intolerance: does desensitization alter the course of the disease?","volume":"29","author":"Klimek","year":"2009","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2020.10.043_bib110","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1034\/j.1398-9995.2001.00025.x","article-title":"Report of the INTERASMA Working Group on Standardization of Inhalation Provocation Tests in Aspirin-induced Asthma. Oral and inhalation provocation tests for the diagnosis of aspirin-induced asthma","volume":"56","author":"Melillo","year":"2001","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.10.043_bib111","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1365-2222.2004.02034.x","article-title":"Increase in urinary leukotriene B4 glucuronide concentration in patients with aspirin-intolerant asthma after intravenous aspirin challenge","volume":"34","author":"Mita","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2020.10.043_bib112","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0002-9149(99)00324-0","article-title":"Aspirin absorption rates and platelet inhibition times with 325-mg buffered aspirin tablets (chewed or swallowed intact) and with buffered aspirin solution","volume":"84","author":"Feldman","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jaci.2020.10.043_bib113","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.anai.2016.11.021","article-title":"Frequency and severity of reactions to a 325-mg aspirin dose during desensitization","volume":"118","author":"Schuler","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib114","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jaci.2018.06.001","article-title":"A trial of type 12 purinergic (P2Y12) receptor inhibition with prasugrel identifies a potentially distinct endotype of patients with aspirin-exacerbated respiratory disease","volume":"143","author":"Laidlaw","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib115","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S1081-1206(10)61101-5","article-title":"Effect of leukotriene modifier drugs on the safety of oral aspirin challenges","volume":"97","author":"White","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib116","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/0091-6749(91)90238-J","article-title":"Tryptase and histamine release during aspirin-induced respiratory reactions","volume":"88","author":"Bosso","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib117","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.anai.2015.12.026","article-title":"Utility of low-dose oral aspirin challenges for diagnosis of aspirin-exacerbated respiratory disease","volume":"116","author":"Jerschow","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib118","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1398-9995.1984.tb02621.x","article-title":"Aspirin tolerance induced in aspirin-sensitive asthmatics","volume":"39","author":"Kowalski","year":"1984","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.10.043_bib119","first-page":"121","article-title":"The influence of misoprostol (synthetic analogue of prostaglandin E1) on aspirin-induced bronchoconstriction in aspirin-sensitive asthma","volume":"6","author":"Szmidt","year":"1996","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib120","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2222.1976.tb01907.x","article-title":"The effect of sodium cromoglycate in preventing aspirin induced bronchospasm","volume":"6","author":"Basomba","year":"1976","journal-title":"Clin Allergy"},{"key":"10.1016\/j.jaci.2020.10.043_bib121","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaci.2007.03.020","article-title":"The relationship between historical aspirin-induced asthma and severity of asthma induced during oral aspirin challenges","volume":"120","author":"Williams","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib122","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0091-6749(82)90081-1","article-title":"Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period","volume":"69","author":"Pleskow","year":"1982","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib123","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jaip.2016.10.021","article-title":"Current knowledge and management of hypersensitivity to aspirin and NSAIDs","volume":"5","author":"Laidlaw","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.10.043_bib124","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2500\/aap.2019.40.4239","article-title":"Long-term assessment of aspirin desensitization shows successful bridging with non-aspirin nonsteroidal anti-inflammatory drugs for procedures","volume":"40","author":"Do","year":"2019","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2020.10.043_bib125","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jaip.2015.03.001","article-title":"Survey-defined patient experiences with aspirin-exacerbated respiratory disease","volume":"3","author":"Ta","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.10.043_bib126","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/j.1365-2036.2010.04465.x","article-title":"Risk factors for NSAID-associated upper GI clinical events in a long-term prospective study of 34 701 arthritis patients","volume":"32","author":"Laine","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaci.2020.10.043_bib127","first-page":"728","article-title":"Practice Parameters Committee of the American College of Gastroenterology. Guidelines for prevention of NSAID-related ulcer complications","volume":"104","author":"Lanza","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2020.10.043_bib128","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/archinte.162.2.169","article-title":"Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole","volume":"162","author":"Graham","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaci.2020.10.043_bib129","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3109\/00365529609010347","article-title":"Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A\u00a0Nordic multicentre study","volume":"31","author":"Ekstrom","year":"1996","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jaci.2020.10.043_bib130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1053\/j.gastro.2011.03.049","article-title":"Acid suppressants reduce risk of gastrointestinal bleeding in patients on antithrombotic or anti-inflammatory therapy","volume":"141","author":"Lin","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2020.10.043_bib131","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2500\/aap.2011.32.3457","article-title":"Aspirin therapy in aspirin-exacerbated respiratory disease: a risk-benefit analysis for the practicing allergist","volume":"32","author":"Baker","year":"2011","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2020.10.043_bib132","doi-asserted-by":"crossref","first-page":"826","DOI":"10.7326\/M15-2112","article-title":"Bleeding\u00a0risks with aspirin use for primary prevention in adults: a systematic review for the U.S. Preventive Services Task Force","volume":"164","author":"Whitlock","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaci.2020.10.043_bib133","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2020.10.043_bib134","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1001\/jama.2018.8194","article-title":"Annual risk of major bleeding among persons without cardiovascular disease not receiving antiplatelet therapy","volume":"319","author":"Selak","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2020.10.043_bib135","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1161\/01.STR.0000174189.81153.85","article-title":"Risk of hemorrhagic stroke with aspirin use: an update","volume":"36","author":"Gorelick","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.jaci.2020.10.043_bib136","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1212\/WNL.0b013e31829e6ffa","article-title":"Antithrombotic drugs and risk of hemorrhagic stroke in the general population","volume":"81","author":"Garcia-Rodriguez","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jaci.2020.10.043_bib137","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jaip.2016.04.028","article-title":"Eosinophilia-associated coronary artery vasospasm in patients with aspirin-exacerbated respiratory disease","volume":"4","author":"Shah","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.10.043_bib138","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.anai.2016.10.018","article-title":"Eosinophilic esophagitis as possible complication of aspirin treatment in patient with aspirin-exacerbated respiratory disease","volume":"118","author":"Pelletier","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib139","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2500\/aap.2013.34.3670","article-title":"The clinical dilemma of \u201csilent desensitization\u201d in aspirin-exacerbated respiratory disease","volume":"34","author":"White","year":"2013","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2020.10.043_bib140","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.anai.2017.05.003","article-title":"Effect of misoprostol on patients with aspirin-exacerbated respiratory disease undergoing aspirin challenge and desensitization","volume":"119","author":"Walters","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib141","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006312.pub2","article-title":"Adrenaline (epinephrine) for the treatment of anaphylaxis with and without shock","author":"Sheikh","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaci.2020.10.043_bib142","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.jaci.2011.12.003","article-title":"Pancreatitis as a novel complication of aspirin therapy in patients with aspirin-exacerbated respiratory disease","volume":"129","author":"Hoyte","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib143","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jaci.2012.10.006","article-title":"Pancreatitis as a complication of aspirin desensitization for\u00a0aspirin-exacerbated respiratory disease","volume":"131","author":"Durrani","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.10.043_bib144","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaci.2013.07.004","article-title":"Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis","volume":"133","author":"Bochenek","year":"2014","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920317085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920317085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:30:42Z","timestamp":1758792642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674920317085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":144,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0091674920317085"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2020.10.043","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of aspirin desensitization followed by oral aspirin therapy in managing patients with aspirin-exacerbated respiratory disease: A\u00a0Work Group Report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of Allergy, Asthma & Immunology","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2020.10.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}